Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy

NCT07844070 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT07844070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07844070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Active, not recruiting
Start date
March 6, 2026
Completion date
October 30, 2026
Enrollment
2,607 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis